Printer Friendly

Bill Martin and Matt Ragas Highlight the Following Stocks: Intel, USA Interactive, Expedia, Frontier, SkyWest, AirTran, Continental, and Southwest.

Business Editors

CHICAGO--(BUSINESS WIRE)--March 21, 2003

Don't let this war shake the foundation of your investments. There are still plenty of opportunities to profit and Bill Martin and Matt Ragas are here to point out several areas that could mean big things for your portfolio. Get their takes on Intel (NASDAQ:INTC), USA Interactive (NASDAQ:USAI), Expedia (NASDAQ:EXPE), Frontier (NASDAQ:FRNT), SkyWest (NASDAQ:SKYW), AirTran (NYSE:AAI), Continental (NYSE:CAL), and Southwest (NYSE:LUV). Click here for the full story exclusively on

Here are the highlights from the Featured Expert column:

Bill and Matt have long made no bones about the fact that even after the washout of the past three years, they still find many blue chip stocks, especially in the tech sector, sporting bloated legacy valuations. Along this same theme, Mike Tarsala of CBS MarketWatch had an interesting column recently, which argues that a number of well known tech blue chips are currently overvalued or at least fully valued, based upon 2004 estimates. One of the names his column looks at not surprisingly is chip giant Intel (NASDAQ:INTC), which Bill and Matt previously said looks like an interesting short at the right price, given its premium, legacy market valuation and limited growth prospects.

With this in mind, Bill and Matt wanted to highlight the section from Tarsala's column on INTC, which includes fund manager David Halford's estimates for INTC: "Halford assumes slightly more modest growth for Intel -- hardly any growth in 2003, and 30 percent growth in 2004. Based on Halford's estimates, Intel would earn about 80 cents a share in 2004 -- a penny more than consensus. Placing a multiple of 25 times earnings on the stock, which is more than Intel's historical PE of about 12 times earnings -- the company's price target at the end of 2004 would be $20 -- close to its current price of $18.25."

Bill and Matt think awarding INTC with a 2004 PE of 25 is extremely generous. Why do Bill and Matt sound so skeptical that INTC can earn 80 cents in 2004? For starters, INTC's EPS growth rate over the past five years has been -6% and sales have risen only 5% over the same period. How's that for flat or no growth!

USA Interactive (NASDAQ:USAI) announced plans to acquire the remaining 46% stake in travel site Expedia (NASDAQ:EXPE) that it didn't already own. Bill and Matt both believe this is a good long term move for USAI shareholders. Bottomline, they believe the recent drop in USAI below the $25 level, which they've said before looks like a great medium to long term entry point into this stock, is another opportunity to pick up a great secular growth stock at a very compelling valuation.

On Monday in their "War Playbook" post, Bill and Matt noted that they were "starting to look at to look at long opportunities in the airline industry since they believe that the industry is rationalizing itself for recovery." A few of the beaten down airline names Bill and Matt are currently watching in this volatile, high risk group include: Frontier (NASDAQ:FRNT), SkyWest (NASDAQ:SKYW), AirTran (NYSE:AAI), Continental (NYSE:CAL). They remain short low cost leader Southwest (NYSE:LUV) in the Tiger Woods portfolio, given its nose-bleed valuation (a 35 PE) and the overall overhang in the industry, but are ready to cover our LUV short at a moments notice.

Get more unique and insight market commentary and stock recommendations from Bill Martin and Matt Ragas on a daily basis by clicking:

About Zacks Featured Experts

To be a successful investor you need professional advice. Experts who know what they're talking about and can help you achieve your financial goals in good markets...and especially in bad ones will help you improve your portfolio. That is why Zacks Investment Research has assembled the best investment experts in the business to offer their powerful advisory newsletters to you on all the major investment topics: Stocks, Mutual Funds, Bonds, Options, Futures etc.

Recommendations from Featured Experts Highlighted in FREE Investment Newsletter

The best way to tap into the powerful advice from these experts is through our free weekly e-mail newsletter, "Profit from the Pros". Each week we highlight several Featured Experts in this free e-mail newsletter. Get your free subscription to "Profit from the Pros" at:

About Zacks is a property of Zacks Investment Research, Inc., which was formed in 1981 to compile, analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind our work is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. Our goal is to unlock their profitable insights for our customers. And there is no better way to enjoy this investment success, than with a FREE subscription to "Profit from the Pros" weekly e-mail newsletter. For your free newsletter, visit

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Mar 21, 2003
Previous Article:David Nichols Recommends the Following Stocks: Clear Channel Communications, Cumulus Media, and Hearst-Argyle Television.
Next Article:Cypress Bioscience Inc. Announces Final Results of Milnacipran Phase II Clinical Trial in Fibromyalgia.

Related Articles
Airline News - North America.
Low Cost Airline News - North America.
Low Cost Airline News - North America.
Low Cost Airline News - North America.
Low Cost Airline News - North America.
Low Cost Airline News - North America.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters